Pharmabiz · 2d
UK’s first norovirus mRNA vaccine trial launched
The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and safety of a norovirus vaccine called mRNA-1403.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results